Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1993 Sep 1;178(3):793–803. doi: 10.1084/jem.178.3.793

I-E+ nonobese diabetic mice develop insulitis and diabetes

PMCID: PMC2191185  PMID: 8350054

Abstract

The development of type I diabetes in the nonobese diabetic (NOD) mouse is under the control of multiple genes, one or more of which is linked to the major histocompatibility complex (MHC). The MHC class II region has been implicated in disease development, with expression of an I-E transgene in NOD mice shown to provide protection from insulitis and diabetes. To examine the effect of expressing an I-E+ or I-E- non-NOD MHC on the NOD background, three I-E+ and three I-E- NOD MHC congenic strains (NOD.H-2i5, NOD.H-2k, and NOD.H-2h2, and NOD.H-2h4, NOD.H-2i7, and NOD.H-2b, respectively) were developed. Of these strains, both I-E+ NOD.H-2h2 and I-E- NOD.H-2h4 mice developed insulitis, but not diabetes. The remaining four congenic strains were free of insulitis and diabetes. These results indicate that in the absence of the NOD MHC, diabetes fails to develop. Each NOD MHC congenic strain was crossed with the NOD strain to produce I-E+ and I-E- F1 mice; these mice thus expressed one dose of the NOD MHC and one dose of a non-NOD MHC on the NOD background. While a single dose of a non-NOD MHC provided a large degree of disease protection to all of the F1 strains, a proportion of I-E+ and I-E- F1 mice aged 5-12 mo developed insulitis and cyclophosphamide-induced diabetes. When I-E+ F1 mice were aged 9-17 mo, spontaneous diabetes developed as well. These data are the first to demonstrate that I-E+ NOD mice develop diabetes, indicating that expression of I-E in NOD mice is not in itself sufficient to prevent insulitis or diabetes. In fact, I-E- F1 strains were no more protected from diabetes than I-E+ F1 strains, suggesting that other non-NOD MHC- linked genes are important in protection from disease. Finally, transfer of NOD bone marrow into irradiated I-E+ F1 recipients resulted in high incidences of diabetes, indicating that expression of non-NOD MHC products in the thymus, in the absence of expression in bone marrow- derived cells, is not sufficient to provide protection from diabetes.

Full Text

The Full Text of this article is available as a PDF (2.5 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acha-Orbea H., McDevitt H. O. The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique. Proc Natl Acad Sci U S A. 1987 Apr;84(8):2435–2439. doi: 10.1073/pnas.84.8.2435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Acha-Orbea H., Scarpellino L. Nonobese diabetic and nonobese nondiabetic mice have unique MHC class II haplotypes. Immunogenetics. 1991;34(1):57–59. doi: 10.1007/BF00212313. [DOI] [PubMed] [Google Scholar]
  3. Ader D. N., Johnson S. B., Huang S. W., Riley W. J. Group size, cage shelf level, and emotionality in non-obese diabetic mice: impact on onset and incidence of IDDM. Psychosom Med. 1991 May-Jun;53(3):313–321. doi: 10.1097/00006842-199105000-00005. [DOI] [PubMed] [Google Scholar]
  4. Atkinson M. A., Maclaren N. K. Autoantibodies in nonobese diabetic mice immunoprecipitate 64,000-Mr islet antigen. Diabetes. 1988 Nov;37(11):1587–1590. doi: 10.2337/diab.37.11.1587. [DOI] [PubMed] [Google Scholar]
  5. Baekkeskov S., Nielsen J. H., Marner B., Bilde T., Ludvigsson J., Lernmark A. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature. 1982 Jul 8;298(5870):167–169. doi: 10.1038/298167a0. [DOI] [PubMed] [Google Scholar]
  6. Bain S. C., Prins J. B., Hearne C. M., Rodrigues N. R., Rowe B. R., Pritchard L. E., Ritchie R. J., Hall J. R., Undlien D. E., Ronningen K. S. Insulin gene region-encoded susceptibility to type 1 diabetes is not restricted to HLA-DR4-positive individuals. Nat Genet. 1992 Nov;2(3):212–215. doi: 10.1038/ng1192-212. [DOI] [PubMed] [Google Scholar]
  7. Bendelac A., Carnaud C., Boitard C., Bach J. F. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells. J Exp Med. 1987 Oct 1;166(4):823–832. doi: 10.1084/jem.166.4.823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Boitard C., Villa M. C., Becourt C., Gia H. P., Huc C., Sempe P., Portier M. M., Bach J. F. Peripherin: an islet antigen that is cross-reactive with nonobese diabetic mouse class II gene products. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):172–176. doi: 10.1073/pnas.89.1.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Böhme J., Schuhbaur B., Kanagawa O., Benoist C., Mathis D. MHC-linked protection from diabetes dissociated from clonal deletion of T cells. Science. 1990 Jul 20;249(4966):293–295. doi: 10.1126/science.2115690. [DOI] [PubMed] [Google Scholar]
  10. Castaño L., Eisenbarth G. S. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol. 1990;8:647–679. doi: 10.1146/annurev.iy.08.040190.003243. [DOI] [PubMed] [Google Scholar]
  11. Cornall R. J., Prins J. B., Todd J. A., Pressey A., DeLarato N. H., Wicker L. S., Peterson L. B. Type 1 diabetes in mice is linked to the interleukin-1 receptor and Lsh/Ity/Bcg genes on chromosome 1. Nature. 1991 Sep 19;353(6341):262–265. doi: 10.1038/353262a0. [DOI] [PubMed] [Google Scholar]
  12. Elliott R. B., Reddy S. N., Bibby N. J., Kida K. Dietary prevention of diabetes in the non-obese diabetic mouse. Diabetologia. 1988 Jan;31(1):62–64. doi: 10.1007/BF00279136. [DOI] [PubMed] [Google Scholar]
  13. Garchon H. J., Bedossa P., Eloy L., Bach J. F. Identification and mapping to chromosome 1 of a susceptibility locus for periinsulitis in non-obese diabetic mice. Nature. 1991 Sep 19;353(6341):260–262. doi: 10.1038/353260a0. [DOI] [PubMed] [Google Scholar]
  14. Harada M., Makino S. Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia. 1984 Dec;27(6):604–606. doi: 10.1007/BF00276978. [DOI] [PubMed] [Google Scholar]
  15. Hattori M., Buse J. B., Jackson R. A., Glimcher L., Dorf M. E., Minami M., Makino S., Moriwaki K., Kuzuya H., Imura H. The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science. 1986 Feb 14;231(4739):733–735. doi: 10.1126/science.3003909. [DOI] [PubMed] [Google Scholar]
  16. Hänninen A., Jalkanen S., Salmi M., Toikkanen S., Nikolakaros G., Simell O. Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest. 1992 Nov;90(5):1901–1910. doi: 10.1172/JCI116067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ikegami H., Makino S., Harada M., Eisenbarth G. S., Hattori M. The cataract Shionogi mouse, a sister strain of the non-obese diabetic mouse: similar class II but different class I gene products. Diabetologia. 1988 Apr;31(4):254–258. doi: 10.1007/BF00290594. [DOI] [PubMed] [Google Scholar]
  18. Julier C., Hyer R. N., Davies J., Merlin F., Soularue P., Briant L., Cathelineau G., Deschamps I., Rotter J. I., Froguel P. Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature. 1991 Nov 14;354(6349):155–159. doi: 10.1038/354155a0. [DOI] [PubMed] [Google Scholar]
  19. Kanazawa Y., Komeda K., Sato S., Mori S., Akanuma K., Takaku F. Non-obese-diabetic mice: immune mechanisms of pancreatic beta-cell destruction. Diabetologia. 1984 Jul;27 (Suppl):113–115. doi: 10.1007/BF00275663. [DOI] [PubMed] [Google Scholar]
  20. Livingstone A., Edwards C. T., Shizuru J. A., Fathman C. G. Genetic analysis of diabetes in the nonobese diabetic mouse. I. MHC and T cell receptor beta gene expression. J Immunol. 1991 Jan 15;146(2):529–534. [PubMed] [Google Scholar]
  21. Lund T., O'Reilly L., Hutchings P., Kanagawa O., Simpson E., Gravely R., Chandler P., Dyson J., Picard J. K., Edwards A. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain. Nature. 1990 Jun 21;345(6277):727–729. doi: 10.1038/345727a0. [DOI] [PubMed] [Google Scholar]
  22. Mark C., Figueroa F., Nagy Z. A., Klein J. Cytotoxic monoclonal antibody specific for the Lyt-1.2 antigen. Immunogenetics. 1982;16(1):95–97. doi: 10.1007/BF00364447. [DOI] [PubMed] [Google Scholar]
  23. Marshak-Rothstein A., Fink P., Gridley T., Raulet D. H., Bevan M. J., Gefter M. L. Properties and applications of monoclonal antibodies directed against determinants of the Thy-1 locus. J Immunol. 1979 Jun;122(6):2491–2497. [PubMed] [Google Scholar]
  24. Miller B. J., Appel M. C., O'Neil J. J., Wicker L. S. Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol. 1988 Jan 1;140(1):52–58. [PubMed] [Google Scholar]
  25. Miyazaki T., Uno M., Uehira M., Kikutani H., Kishimoto T., Kimoto M., Nishimoto H., Miyazaki J., Yamamura K. Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice. Nature. 1990 Jun 21;345(6277):722–724. doi: 10.1038/345722a0. [DOI] [PubMed] [Google Scholar]
  26. Nepom B. S., Palmer J., Kim S. J., Hansen J. A., Holbeck S. L., Nepom G. T. Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis. J Exp Med. 1986 Jul 1;164(1):345–350. doi: 10.1084/jem.164.1.345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Nepom G. T. A unified hypothesis for the complex genetics of HLA associations with IDDM. Diabetes. 1990 Oct;39(10):1153–1157. doi: 10.2337/diab.39.10.1153. [DOI] [PubMed] [Google Scholar]
  28. Nishimoto H., Kikutani H., Yamamura K., Kishimoto T. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. 1987 Jul 30-Aug 5Nature. 328(6129):432–434. doi: 10.1038/328432a0. [DOI] [PubMed] [Google Scholar]
  29. Prochazka M., Leiter E. H., Serreze D. V., Coleman D. L. Three recessive loci required for insulin-dependent diabetes in nonobese diabetic mice. Science. 1987 Jul 17;237(4812):286–289. doi: 10.1126/science.2885918. [DOI] [PubMed] [Google Scholar]
  30. Prochazka M., Serreze D. V., Worthen S. M., Leiter E. H. Genetic control of diabetogenesis in NOD/Lt mice. Development and analysis of congenic stocks. Diabetes. 1989 Nov;38(11):1446–1455. doi: 10.2337/diab.38.11.1446. [DOI] [PubMed] [Google Scholar]
  31. Rotella C. M., Dotta F., Mannucci E., Di Mario U. Autoantigens in thyroid and islet autoimmunity: similarities and differences. Autoimmunity. 1992;12(3):223–237. doi: 10.3109/08916939209148463. [DOI] [PubMed] [Google Scholar]
  32. Sarmiento M., Glasebrook A. L., Fitch F. W. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J Immunol. 1980 Dec;125(6):2665–2672. [PubMed] [Google Scholar]
  33. Sher A., Gazzinelli R. T., Oswald I. P., Clerici M., Kullberg M., Pearce E. J., Berzofsky J. A., Mosmann T. R., James S. L., Morse H. C., 3rd Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol Rev. 1992 Jun;127:183–204. doi: 10.1111/j.1600-065x.1992.tb01414.x. [DOI] [PubMed] [Google Scholar]
  34. Slattery R. M., Kjer-Nielsen L., Allison J., Charlton B., Mandel T. E., Miller J. F. Prevention of diabetes in non-obese diabetic I-Ak transgenic mice. Nature. 1990 Jun 21;345(6277):724–726. doi: 10.1038/345724a0. [DOI] [PubMed] [Google Scholar]
  35. Supon P., Stecha P., Haskins K. Anti-islet cell antibodies from NOD mice. Diabetes. 1990 Nov;39(11):1366–1372. doi: 10.2337/diab.39.11.1366. [DOI] [PubMed] [Google Scholar]
  36. Tochino Y. The NOD mouse as a model of type I diabetes. Crit Rev Immunol. 1987;8(1):49–81. [PubMed] [Google Scholar]
  37. Todd J. A., Aitman T. J., Cornall R. J., Ghosh S., Hall J. R., Hearne C. M., Knight A. M., Love J. M., McAleer M. A., Prins J. B. Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature. 1991 Jun 13;351(6327):542–547. doi: 10.1038/351542a0. [DOI] [PubMed] [Google Scholar]
  38. Todd J. A., Bell J. I., McDevitt H. O. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature. 1987 Oct 15;329(6140):599–604. doi: 10.1038/329599a0. [DOI] [PubMed] [Google Scholar]
  39. Todd J. A. Genetic analysis of susceptibility to type 1 diabetes. Springer Semin Immunopathol. 1992;14(1):33–58. doi: 10.1007/BF00197131. [DOI] [PubMed] [Google Scholar]
  40. Uehira M., Uno M., Kürner T., Kikutani H., Mori K., Inomoto T., Uede T., Miyazaki J., Nishimoto H., Kishimoto T. Development of autoimmune insulitis is prevented in E alpha d but not in A beta k NOD transgenic mice. Int Immunol. 1989;1(2):209–213. doi: 10.1093/intimm/1.2.209. [DOI] [PubMed] [Google Scholar]
  41. Uno M., Miyazaki T., Uehira M., Nishimoto H., Kimoto M., Miyazaki J., Yamamura K. Complete prevention of diabetes in transgenic NOD mice expressing I-E molecules. Immunol Lett. 1992 Jan;31(1):47–52. doi: 10.1016/0165-2478(92)90009-d. [DOI] [PubMed] [Google Scholar]
  42. Wicker L. S., Miller B. J., Coker L. Z., McNally S. E., Scott S., Mullen Y., Appel M. C. Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse. J Exp Med. 1987 Jun 1;165(6):1639–1654. doi: 10.1084/jem.165.6.1639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Wicker L. S., Miller B. J., Fischer P. A., Pressey A., Peterson L. B. Genetic control of diabetes and insulitis in the nonobese diabetic mouse. Pedigree analysis of a diabetic H-2nod/b heterozygote. J Immunol. 1989 Feb 1;142(3):781–784. [PubMed] [Google Scholar]
  44. Wilberz S., Partke H. J., Dagnaes-Hansen F., Herberg L. Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. Diabetologia. 1991 Jan;34(1):2–5. doi: 10.1007/BF00404016. [DOI] [PubMed] [Google Scholar]
  45. Williams A. J., Krug J., Lampeter E. F., Mansfield K., Beales P. E., Signore A., Gale E. A., Pozzilli P. Raised temperature reduces the incidence of diabetes in the NOD mouse. Diabetologia. 1990 Oct;33(10):635–637. doi: 10.1007/BF00400211. [DOI] [PubMed] [Google Scholar]
  46. Yasunami R., Bach J. F. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur J Immunol. 1988 Mar;18(3):481–484. doi: 10.1002/eji.1830180325. [DOI] [PubMed] [Google Scholar]
  47. Ziegler A. G., Vardi P., Ricker A. T., Hattori M., Soeldner J. S., Eisenbarth G. S. Radioassay determination of insulin autoantibodies in NOD mice. Correlation with increased risk of progression to overt diabetes. Diabetes. 1989 Mar;38(3):358–363. doi: 10.2337/diab.38.3.358. [DOI] [PubMed] [Google Scholar]
  48. de Gouyon B., Melanitou E., Richard M. F., Requarth M., Hahn I. H., Guenet J. L., Demenais F., Julier C., Lathrop G. M., Boitard C. Genetic analysis of diabetes and insulitis in an interspecific cross of the nonobese diabetic mouse with Mus spretus. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1877–1881. doi: 10.1073/pnas.90.5.1877. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES